Orgenesis Inc. Common Stock
ORGS
ORGS was delisted on the 18th of October, 2024.
14 hedge funds and large institutions have $1.53M invested in Orgenesis Inc. Common Stock in 2018 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 0 closing their positions.
50% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 2
40% more funds holding
Funds holding: 10 → 14 (+4)
6% less capital invested
Capital invested by funds: $1.62M → $1.53M (-$90K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$619K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$43K |
| 3 |
BlackRock
New York
|
+$5.48K |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$4.13K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$3.59K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$67.7K |
| 2 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
-$3.92K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Vanguard Group
Malvern,
Pennsylvania
| $1.31M | +$619K | +9,150 | +63% |
|
|
2
BlackRock
New York
| $111K | +$5.48K | +81 | +4% |
|
|
PAM
3
Panagora Asset Management
Boston,
Massachusetts
| $56K | -$3.92K | -58 | -5% |
|
|
4
UBS Group
Zurich,
Switzerland
| $35K | +$43K | +636 | +10,600% |
|
5
Citigroup
New York
| $7K | – | – | – |
|
|
WEC
6
Winslow Evans & Crocker
Boston,
Massachusetts
| $6K | – | – | – |
|
|
TRCT
7
Tower Research Capital (TRC)
New York
| $3K | +$3.59K | +53 | New |
|
|
8
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| $3K | +$4.13K | +61 | New |
|
|
9
Morgan Stanley
New York
| $1K | -$67.7K | -1,000 | -99% |
|
10
Bank of America
Charlotte,
North Carolina
| $1K | – | – | – |
|
|
SFG
11
SevenBridge Financial Group
Harrisburg,
Pennsylvania
| $1K | – | – | – |
|
12
Fidelity Investments
Boston,
Massachusetts
| $1K | +$1.01K | +15 | New |
|
13
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | +$135 | +2 | New |
|
ORGS Hedge Fund Activity: Q3 2018 in Review
14 of the 4,375 institutional investors tracked by Wall St. Rank reported a position in Orgenesis Inc. Common Stock (ORGS) for Q3 2018, worth a combined $1.53M — down 5.5% from $1.62M a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new ORGS positions and 0 closed out — a net gain of 4 holders — while 3 added to existing stakes and 2 trimmed.
The largest buyer was Vanguard Group, adding an estimated $619K. The largest seller was Morgan Stanley, cutting an estimated $67.7K.
- 14 institutional investors held Orgenesis Inc. Common Stock (ORGS) as of Q3 2018, up from 10 in Q2 2018.
- Funds reported $1.53M of Orgenesis Inc. Common Stock stock for Q3 2018, down 5.5% quarter-over-quarter.
- 4 funds opened new Orgenesis Inc. Common Stock positions in Q3 2018 and 0 closed out, a net change of +4 holders.
- The largest Orgenesis Inc. Common Stock buyer in Q3 2018 was Vanguard Group, an estimated $619K added.
- The largest Orgenesis Inc. Common Stock seller in Q3 2018 was Morgan Stanley, an estimated $67.7K sold.
Based on aggregated 13F filings for Q3 2018.